Colombia
7 Vaccines Approved for Use in Colombia
Protein Subunit
Anhui Zhifei Longcom
Zifivax
Approved in 4 countries
21 trials in 5 countries
Approval Source: elespectador.com
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 149 countries
100 trials in 31 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Approval Source: reuters.com
Inactivated
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Approval Source: reuters.com
8 in Clinical Trials in Colombia
Protein Subunit
Clover
SCB-2019
15 trials in 13 countries
DNA
Inovio
INO-4800
10 trials in 9 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 149 countries
73 trials in 34 countries
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Jcovden
Approved in 113 countries
26 trials in 25 countries
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
42 trials in 10 countries
Inactivated
Sinovac
Trivalent COVID-19 Vaccine (Vero Cell), Inactivated
Inactivated
Valneva
VLA2001
Approved in 33 countries
9 trials in 4 countries
1 Vaccines with Trials in Colombia are No Longer Progressing
RNA
Curevac
CVnCoV
9 trials in 12 countries